Cystic changes in hepatic and peritoneal metastases from gastrointestinal stromal tumors treated with Gleevec

Abdominal Imaging

Volumn 28, Issue 6, 2003, Pages 808-814

  Bechtold, R E ^a   Chen, M Y M ^a   Stanton, C A ^a   Savage, P D ^a   Levine, E A ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

CT; Gastrointestinal tract; Liver neoplasm; Metastases; Neoplasms

Indexed keywords

CONTRAST MEDIUM; IMATINIB;

ADULT; AGED; ARTICLE; CANCER REGRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; LIVER CYST; LIVER METASTASIS; LONG TERM CARE; MALE; NECROSIS; PERITONEUM METASTASIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TUMOR CELL; TUMOR VOLUME;

EID: 0242268100     PISSN: 09428925     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00261-003-0021-2     Document Type: Article

References (14)

1. Berman J, O'Leary TJ. Gastrointestinal stromal tumor workshop. Hum Pathol 2001;32:578-582
2. DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann Surg 2000;231:51-58
3. Joensuu H, Robert PJ, Sarlomo-Rikala M, et al. Brief report: effect of the tyrosine kinase inhibitor STI 571 in a patient with a metastatic gastrointestinal stromal tumor. N Engl J Med 2001;344:1052-1056
4. Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N Engl J Med 2002;347:472-480
5. Chen MYM, Bechtold RE, Savage PD. Cystic changes in hepatic metastases from gastrointestinal stromal tumors (GIST) treated with Gleevec (Imatinib mesylate). AJR 2002;179:1059-1062
6. Miettinen M, Sarlomo-Rikala M, Lasota J. Gastrointestinal stromal tumors: recent advances in understanding of their biology. Hum Pathol 1999;30:1213-1220
7. Sarlomo-Rikala M, Kovatich AJ, Barusevicius A, Miettinen M. CD117: a sensitive marker for gastrointestinal stromal tumors that is more specific than CD 34. Mod Pathol 1998;11:728-734
8. Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia. N Engl J Med 2001;344:1031-1037
9. Heinrich MC, Blanke CD, Druker BJ, Corless CL. Inhibition of KIT tyrosine kinase activity: a novel molecular approach to the treatment of KIT-positive malignancies. J Clin Oncol 2002;20:1692-1703
10. Emory TS, Sobin LH, Lukes L, et al. Prognosis of gastrointestinal smooth-muscle (stromal) tumors: dependence on anatomic site. Am J Surg Pathol 1999;23:82-87
11. Baker ME, Pelley R. Hepatic metastases: basic principles and implications for radiologists. Radiology 1995;197:329-337
12. Sica GT, Ji H, Ros PR. CT and MR imaging of hepatic metastases. AJR 2000;174:691-698
13. Baron RL. Detection of liver neoplasms: technique and outcomes. Abdom Imaging 1994;19:320-324
14. Hasegawa S, Semelka RC, Noone TC, et al. Gastric stromal sarcomas: correlation of MR imaging and histopathologic findings in nine patients. Radiology 1998;208:591-595